Anti-Inflammatory Activity and Mechanism of Stearic Acid Extract From Purslane
- PMID: 40654533
- PMCID: PMC12245719
- DOI: 10.1002/fsn3.70596
Anti-Inflammatory Activity and Mechanism of Stearic Acid Extract From Purslane
Abstract
Purslane, as a traditional edible and medicinal herb, has been proven to have good anti-inflammatory activity. In this study, it was clarified that stearic acid was the main anti-inflammatory substance in purslane and could decrease the secretion of inflammatory cytokines, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and interleukin-10 (IL-10) in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. Meanwhile, the inhibitory effect of liposoluble extract of purslane (PLE) and stearic acid on LPS-induced ulcerative enteritis was determined. LPS-induced enteritis, including body weight loss, reduced weight of the small intestine, and histological intestinal damage, was significantly ameliorated in mice fed PLE and stearic acid. In particular, PLE could significantly reduce the levels of TNF-α, IL-6, and interleukin-1β (IL-1β) in the small intestine through NF-κB and MAPK signaling pathways. Thus, our results proved that purslane could be considered a natural anti-inflammatory medicine to combat LPS-induced inflammation and provide a theoretical basis for future applications in the field of medicine or functional food.
Keywords: anti‐inflammatory activity; inflammatory bowel diseases; purslane; stearic acid.
© 2025 The Author(s). Food Science & Nutrition published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures







References
-
- Chen, R. , Wang X.‐J., Zhang Y.‐Y., et al. 2019. “Simultaneous Extraction and Separation of Oil, Proteins, and Glucosinolates From <styled-content style="fixed-case"> Moringa oleifera </styled-content> Seeds.” Food Chemistry 300: 125162. - PubMed
-
- Chen, X. , Li W., Chen T., et al. 2022. “miR‐146a‐5p Promotes Epithelium Regeneration Against LPS‐Induced Inflammatory Injury via Targeting TAB1/TAK1/NF‐κB Signaling Pathway.” International Journal of Biological Macromolecules 221: 1031–1040. - PubMed
-
- Cheung, F. 2011. “TCM: Made in China.” Nature 480: S82–S83. - PubMed
-
- Del Sordo, R. , Lougaris V., Bassotti G., Armuzzi A., and Villanacci V.. 2022. “Therapeutic Agents Affecting the Immune System and Drug‐Induced Inflammatory Bowel Disease (IBD): A Review on Etiological and Pathogenetic Aspects.” Clinical Immunology 234: 108916. - PubMed
LinkOut - more resources
Full Text Sources